Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Q32 BIO INC.(FIXX) | 320,482 | 320,482 | 0 | 5,753 | 14,300 | 5.49% | +8,547 |
| ERASCA, INC.(ERAS) | 11,055,554 | 11,055,554 | 0 | 26,091 | 30,182 | 11.58% | +4,091 |
| SINGULAR GENOMICS SYSTEMS, INC. | 126,630 | 126,630 | 0 | 1,070 | 1,984 | 0.76% | +914 |
| GOSSAMER BIO, INC.(GOSS) | 8,055,916 | 8,055,916 | 0 | 7,258 | 7,946 | 3.05% | +689 |
| UNITY BIOTECHNOLOGY, INC. | 1,004,817 | 1,004,817 | 0 | 1,357 | 1,477 | 0.57% | +121 |
| VERVE THERAPEUTICS, INC. | 2,008,809 | 2,008,809 | 0 | 9,803 | 9,723 | 3.73% | -80 |
| CERO THERAPEUTICS HOLDINGS, INC.(CERO) | 1,444,296 | 1,444,296 | 0 | 432 | 135 | 0.05% | -297 |
| BEAM THERAPEUTICS INC.(BEAM) | 5,443,039 | 4,834,653 | -608,386 | 127,530 | 118,449 | 45.46% | -9,081 |
| RAPPORT THERAPEUTICS, INC.(RAPP) | 3,728,738 | 3,728,738 | 0 | 86,730 | 76,365 | 29.31% | -10,366 |